Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
N/A
-3,322,300 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
N/A
157,100 Added 4.96%
3,322,300 $32.2 Million
Q1 2021

May 17, 2021

BUY
N/A
205,000 Added 6.93%
3,165,200 $34 Million
Q4 2020

Feb 16, 2021

BUY
N/A
1,707,600 Added 136.32%
2,960,200 $43.5 Million
Q3 2020

Nov 16, 2020

BUY
N/A
41,600 Added 3.44%
1,252,600 $17.8 Million
Q2 2020

Aug 14, 2020

BUY
N/A
410,000 Added 51.19%
1,211,000 $9.8 Million
Q1 2020

May 15, 2020

BUY
N/A
801,000 New
801,000 $3.24 Million

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.